Application in a Post-Mohs surgery – Basal Cell Carcinoma

Micheal N. Desvigne, MD, FACS, CWS, FACCWS

Valley Wound Care Specialists, and Abrazo Arrowhead Hospital, Glendale, Arizona

Initial Presentation

Week 3

Results

Fully re-epithelialized at week 3
Minimal scar contracture
No distortion of cupids bow

Patient details

75-year-old female

Medical history

Mohs surgery performed for basal cell carcinoma on upper lip
History of skin cancer excision’s same location

Case details

Wound Age: 0 weeks
Previous Treatments: None
Treatment: Endoform Natural covered with antibiotic ointment and non-adherent dressing
Wound size: 1.2 cm x 1.2 cm following excision

Application photos

Results may vary. Dr. Michael Desvigne has a consultancy agreement with Aroa Biosurgery Limited.

Clinical applications

Products

Resources

Why Aroa

Support

About

Legal

© 2025 Aroa Biosurgery Ltd.

References

Lawlor et al (2024). Plastic and Reconstructive Surgery – Global Open 12(12): e6406
Cormican et al (2023). ePlasty 23: e66
Bosque et al (2023). J Am Podiatr Med Assoc 113(3): 22-081
Taarea et al (2014). Trauma Cases Rev 10(1): 102
Chaffin et al (2021). J Wound Care 30(Sup7): S28-S34
Chaffin et al (2020). J Wound Care 29(11):624-630
Bohn et al (2020). J Wound Care 29(12): 742-749
Tsu et al (2020). Oral and Maxillofacial Surgery Cases 10(3): 100369
Dempsey et al (2019). Proteome Res 18(4): 1657-1668
Smith et al (2021). J Biomater Appl 36(6): 996-1010
Desvigne et al (2021). Front Surg 7: 559450
Negron et al (2014). Int Wound J 11(4): 392-397
Data on file
Overbeck et al (2020). Hernia. 24(6):1293-1306
Irvine et al (2011). Biomaterials. 32(27):6351-6361

View all references